文献速递主动脉疾病

降主动脉及胸腹主动脉瘤修复术后长期生存分析

Long-term survival after descending thoracic and thoracoabdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2021-03-26

该研究回顾性分析了1983至2015年间946例接受开放或腔内修复的降主动脉及胸腹主动脉瘤患者,中位随访102.8个月。围术期死亡率合理,主动脉相关死亡率仅2.1%;年龄、手术年代、急性病理、夹层、术前肌酐及IV型胸腹主动脉瘤与远期死亡相关,术后神经、心脏和肺部并发症亦与死亡相关。急性病例中腔内修复较开放修复长期生存更优,非急性病例两者无差异。

要点

  • 胸腹主动脉瘤修复术后主动脉相关死亡率低(2.1%)。
  • 年龄、急性病理、夹层、术前肌酐及IV型TAAA与远期死亡相关。
  • 急性病例腔内修复长期生存优于开放,非急性两者无差异。

核心结论

  • 胸腹主动脉瘤可修复且围术期死亡率合理,修复后主动脉相关死亡率低。
  • 腔内修复的加入显著改变了降主动脉及胸腹主动脉瘤的治疗格局。
  • 急性病例中腔内修复与围术期死亡率降低和长期生存显著改善相关。

研究设计与样本

  • 单中心前瞻性维护数据库的回顾性综述,纳入1983至2015年接受开放或腔内修复的降主动脉或胸腹主动脉瘤患者。
  • 排除因创伤性横断而干预的患者,共946例符合标准,中位随访102.8个月(IQR 58.9-148.2个月)。
  • 中位年龄71岁(IQR 63-77岁),男性占58.1%;TAAA分型:I型14.2%、II型21.2%、III型17.1%、IV型26.2%、dTAA 21.2%。
  • 147例(15.5%)有既往夹层,动脉瘤中位直径6.4 cm(IQR 6.0-7.0 cm),158例(16.7%)接受腔内修复。

主要发现

  • 与远期死亡相关的变量包括年龄、手术年代、急性病理、夹层、术前肌酐及IV型TAAA。
  • 术后神经、心脏和肺部并发症亦与远期死亡相关。
  • 研究期间主动脉相关死亡为2.1%(n=20)。
  • 急性病例中腔内修复较开放修复长期生存更好,非急性病例两种修复方式长期生存无差异。
  • 更现代年代的手术与生存改善相关。

临床怎么用

  • 胸腹主动脉瘤修复后需长期随访管理合并症和并发症,因其是远期死亡的主要贡献因素。
  • 急性降主动脉或胸腹主动脉瘤病例可考虑腔内修复以改善长期生存。
  • 非急性病例开放与腔内修复长期生存相当,选择需个体化。

局限性

  • 单中心回顾性研究,数据来自1983至2015年,手术年代跨度大可能影响结果。
  • 仅纳入符合修复标准的患者,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with descending thoracic aortic aneurysms (dTAA) or thoracoabdominal aortic aneurysms (TAAA) often have a variety of medical comorbidities. Those that are deemed acceptable for intervention undergo complicated repairs with good early outcomes. The purpose of this study was to identify variables that were associated with mortality over time. METHODS: This was a retrospective review of a prospectively maintained database at our institution from 1983 to 2015. Patients were included if they underwent open or endovascular repair for dTAA or TAAA. Patients were excluded if they were intervened on for traumatic transections. The primary outcome for the study was long-term survival. Secondary outcomes included aortic-related mortality. We had mortality and survival data on all patients. RESULTS: A total of 946 patients met our study criteria with a median follow-up of 102.8 months (interquartile range [IQR], 58.9-148.2 months). The median age of the cohort was 71 years (IQR, 63-77 years) with the majority of patients being male (58.1%). The extent of TAAA pathology was as follows: type I (14.2%), type II (21.2%), type III (17.1%), type IV (26.2%), and dTAA (21.2%). A total of 147 patients (15.5%) had a prior dissection. The median diameter of aneurysm was 6.4 cm (IQR, 6.0-7.0 cm). A total of 158 patients (16.7%) underwent endovascular repair over the study period. Variables associated with mortality over time were age, surgical era, acute pathology, dissection, preoperative creatinine, and type IV TAAAs. In addition, experiencing the following complications in the postoperative period was associated with mortality over time: neurological, cardiac, and pulmonary. Aortic-related mortality was 2.1% (n = 20) over the study period. Patients who underwent endovascular repair for acute conditions had better long-term survival when compared with open repair. However, there were no differences in long-term survival between open and endovascular repair for nonacute cases. In addition, repair in the more modern era was associated with improved survival. CONCLUSIONS: TAAAs can be repaired with reasonable perioperative mortality rates. Once patients undergo repair of their aneurysm, aortic-related mortality remains low. The addition of endovascular options has dramatically changed management of patients with dTAA and TAAA. Further, endovascular repair was associated with decreased perioperative mortality and significantly increased long-term survival in acute patients. Patients undergoing TAAA repair are generally considered high risk and therefore require extensive long-term follow-up for management of their comorbidities and complications, because these are the main contributors to mortality over time.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Khoury MK, Acher C, Wynn MM, et al. Long-term survival after descending thoracic and thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2021. PMID: 33775746. doi:10.1016/j.jvs.2021.02.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。